89 studies found for:    vaccine adverse reactions | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
vaccine adverse reactions | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV
Condition: Smallpox Vaccine Adverse Reaction
Intervention: Biological: Vaccination with ACAM2000
2 Not yet recruiting A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
Condition: Staphylococcus Aureus Infection
Interventions: Biological: Low dosage of Staphylococcus aureus vaccine (15µg/0.6ml);   Biological: Middle dosage of Staphylococcus aureus vaccine (30µg/0.6ml);   Biological: High dosage of Staphylococcus aureus vaccine (60µg/0.6ml);   Biological: Placebo
3 Recruiting A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older
Condition: Influenza
Interventions: Biological: Quadrivalent influenza vaccine;   Biological: Trivalent influenza vaccine A;   Biological: Trivalent influenza vaccine B
4 Recruiting A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
Condition: Staphylococcus Aureus Infection
Interventions: Biological: Staphylococcus aureus vaccine (60µg/per protein);   Biological: Staphylococcus aureus vaccine (30µg/per protein);   Biological: Staphylococcus aureus vaccine (15µg/per protein)
5 Recruiting A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults
Condition: Hepatitis E
Interventions: Biological: 30μg/0.5ml Hepatitis E vaccine;   Biological: 30μg/0.5ml Recombinant Hepatitis E vaccine
6 Recruiting A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
Conditions: Hepatitis E;   Hepatitis B
Interventions: Biological: HEV vaccine;   Biological: HBV vaccine
7 Not yet recruiting Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old
Condition: Enterovirus 71 Vaccine
Intervention: Biological: two doses enterovirus 71 vaccine
8 Recruiting Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older
Condition: Quadrivalent Influenza Virus Vaccine
Intervention: Biological: One dose of Quadrivalent Influenza Virus Vaccine
9 Not yet recruiting A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Condition: Shigella Sonnei Infection
Interventions: Biological: S. sonnei vaccine 25 μg;   Biological: S. sonnei vaccine 100 μg;   Biological: Menveo;   Biological: Boostrix
10 Recruiting Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Condition: Dengue
Interventions: Biological: Dengue 1,2,3,4 (attenuated) vaccine;   Other: Placebo
11 Not yet recruiting Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
Condition: Influenza
Interventions: Biological: one dose of Influenza Vaccine;   Biological: placebo
12 Not yet recruiting Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)
Condition: Diseases Caused by Streptococcus Pneumoniae Serotypes
Interventions: Biological: 7-valent pneumococcal conjugate vaccine;   Biological: 13-valent pneumococcal polysaccharide conjugate vaccine
13 Recruiting A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
Condition: Hepatitis B, Chronic
Intervention: Biological: CVI-HBV-002
14 Not yet recruiting A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
Condition: Pneumonia
Interventions: Biological: 13-valent pneumococcal conjugate vaccine;   Biological: 7-valent pneumococcal conjugate vaccine
15 Recruiting HBV Vaccine in Renal Failure Patients
Condition: Renal Failure
Interventions: Biological: Intradermal HBVv with imiquimod;   Biological: Intradermal HBVv with aqueous cream;   Biological: Intramuscular HBVv with aqueous cream
16 Recruiting VZV Vaccine for Hematopoietic Stem Cell Transplantation
Condition: Varicella Zoster Infection
Interventions: Biological: Zostavax;   Biological: Normal Saline
17 Unknown  Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Conditions: High Risk HLA-A2+ Melanoma;   Metastatic Disease
Intervention: Biological: Melanoma vaccine modified to express HLA A2/4-1BB ligand
18 Unknown  Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine
Condition: Influenza
Intervention: Biological: 2012 trivalent influenza vaccine
19 Unknown  The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Condition: Varicella
Interventions: Biological: HBV-3;   Biological: HBV-6;   Biological: varicella-3;   Biological: varicella-6
20 Recruiting Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers
Condition: Typhoid Fever
Intervention: Biological: Vivotif

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years